CCO Independent Conference Coverage of the AASLD Conference 2020

November 13-16, 2020; Virtual
In this downloadable slideset, CCO’s expert faculty summarize emerging data on HBV management and treatment, discuss progress on identifying risk for hepatocellular carcinoma, and examine emerging trends in HCV treatment outcomes.
Norah Terrault Headshot
Norah Terrault, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 4.4 MB
Released: November 25, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences

Related Content

Expert Clinical Care Options (CCO) commentary on racial disparities in HBV care among Caribbean immigrant communities in the US

Patricia D. Jones, MD, MSCR Released: June 7, 2021

Clinical Care Options (CCO) expert Dr. Norah Terrault on HCC risk scores to inform personalized HCC surveillance in patients with chronic hepatitis B

Norah Terrault Headshot Norah Terrault, MD, MPH Released: June 4, 2021

Expert Clinical Care Options (CCO) commentary by Dr Ira Jacobson on treatment decisions for immune-tolerant HBV

Ira M. Jacobson, MD Released: May 14, 2021

臨床ケアオプション(CCO)の専門家である田中靖人博士は、新規の血清バイオマーカーである HBcrAgを使って、慢性B型肝炎の患者さんのHCCリスクを予測します

person default Yasuhito Tanaka, MD, PhD Released: May 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue